Skip to main content
RDNT
NASDAQ Industrial Applications And Services

RadNet Reports Record Q4 Revenue & EBITDA, Exceeds 2025 Guidance, and Issues Strong 2026 Outlook

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$75.01
Mkt Cap
$5.403B
52W Low
$45.001
52W High
$85.84
Market data snapshot near publication time

summarizeSummary

RadNet, Inc. announced record fourth quarter and full-year 2025 revenue and Adjusted EBITDA, surpassing its own guidance, and provided robust 2026 financial projections driven by strong imaging center performance and strategic growth in its Digital Health segment.


check_boxKey Events

  • Record Q4 & FY 2025 Financials

    RadNet reported record fourth quarter 2025 revenue of $547.7 million (up 14.8%) and Adjusted EBITDA of $87.7 million (up 16.9%). Full-year 2025 revenue reached $2.04 billion and Adjusted EBITDA was $300.2 million.

  • Exceeded 2025 Guidance

    The company surpassed its previously upwardly revised 2025 guidance levels for both Imaging Center segment revenue and Adjusted EBITDA.

  • Strong 2026 Financial Guidance

    RadNet issued robust 2026 guidance, projecting Imaging Center segment revenue growth of 17%-19% and Adjusted EBITDA growth of 18%-22%. Digital Health revenue is anticipated to grow 46%-56%.

  • Digital Health Strategic Growth

    The Digital Health segment is set for accelerated growth, bolstered by the acquisition of Gleamer and expectations for a minimum of four FDA clearances in 2026, expanding its AI solutions portfolio.


auto_awesomeAnalysis

RadNet, Inc. delivered a strong financial performance, reporting record fourth quarter and full-year 2025 revenue and Adjusted EBITDA, which exceeded its previously raised guidance. The company's robust 2026 financial guidance, particularly the significant growth projected for its Digital Health segment, indicates positive momentum. While the company reported a GAAP net loss for both the fourth quarter and full year 2025, management highlighted that this was impacted by unusual or one-time items, emphasizing the strength of adjusted metrics and operational growth. The strategic acquisition of Gleamer and anticipated FDA clearances for AI solutions in Digital Health are key drivers for future growth and market leadership.

At the time of this filing, RDNT was trading at $75.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $45.00 to $85.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed RDNT - Latest Insights

RDNT
Apr 20, 2026, 5:15 PM EDT
Filing Type: DEF 14A
Importance Score:
7
RDNT
Mar 02, 2026, 5:25 PM EST
Source: Wiseek News
Importance Score:
8
RDNT
Mar 02, 2026, 5:17 PM EST
Filing Type: 10-K
Importance Score:
8
RDNT
Mar 02, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
RDNT
Mar 02, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
RDNT
Mar 02, 2026, 6:01 AM EST
Source: Dow Jones Newswires
Importance Score:
7
RDNT
Mar 02, 2026, 5:45 AM EST
Source: Dow Jones Newswires
Importance Score:
8
RDNT
Jan 09, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7